Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Prosteez is an Ayurvedic herbomineral formulation developed by Charak Pharma to support prostate health and maintain healthy urinary function in men. It is primarily indicated for the management of symptoms associated with benign prostatic hyperplasia (BPH) and prostatitis. The formulation contains a synergistic blend of standardized herbal extracts and minerals, including saw palmetto (*Serenoa repens*), varuna (*Crataeva nurvala*), gokshura (*Tribulus terrestris*), kanchanar (*Bauhinia variegata*), soya (*Glycine max*), guduchi (*Tinospora cordifolia*), triphala, shilajit, and yashad bhasma (zinc calx). These ingredients work together to reduce prostate size, ease urinary obstruction, alleviate urinary frequency and urgency, and provide anti-inflammatory and antioxidant support.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Prosteez.